Nanoparticles can be found in processed food (e.g. food additives), consumer products (e.g. sunscreen) and even in medicine. While these tiny particles could have large untapped potential and novel new applications, they may have unintended and harmful side effects, according to a recent study by researchers from the National University of Singapore (NUS).
Specifically, NUS researchers found that cancer nanomedicine, which are designed to kill cancer cells, may accelerate metastasis. Using breast cancer as a model, they discovered that common nanoparticles made from gold, titanium dioxide, silver and silicon dioxide – and also used in nanomedicines – widen the gap between blood vessel cells, making it easier for other cells, such as cancer cells, to go in and out of “leaky” blood vessels.

The phenomenon, named ‘nanomaterials induced endothelial leakiness’ (NanoEL) by the NUS team, accelerates the movement of cancer cells from the primary tumour and also causes circulating cancer cells to escape from blood circulation. This results in faster establishment of a bigger secondary tumour site and initiates new secondary sites previously not accessible to cancer cells.

“For a cancer patient, the direct implication of our findings is that long term, pre-existing exposure to nanoparticles – for instance, through everyday products or environmental pollutants – may accelerate cancer progression, even when nanomedicine is not administered,” explained research co-leader Associate Professor David Leong from the Department of Chemical and Biomolecular Engineering at NUS Faculty of Engineering.

He added, “The interactions between these tiny nanomaterials and the biological systems in the body need to be taken into consideration during the design and development of cancer nanomedicine. It is crucial to ensure that the nanomaterial delivering the anti-cancer drug does not also unintentionally accelerate tumour progression. As new breakthroughs in nanomedicine unfold, we need to concurrently understand what causes these nanomaterials to trigger unexpected outcomes.”

The study, jointly led by Assoc Prof Leong and Associate Professor Ho Han Kiat from the Department of Pharmacy at NUS Faculty of Science, was published in scientific journal Nature Nanotechnology (“Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness”).

Image Credit:  National University of Singapore

Read more at nanowerk.com

News This Week

A ‘cancer lab’ on chip

Finding out you have cancer is bad enough, but to then have to go to hospital for a painful and invasive biopsy to try to identify the exact type of tumor can be deeply [...]

Nanoparticles Heal Spinal Cord Injuries

The zealous immune response to injuries is known to cause paralyzing damage in spinal cord injury (SCI). Engineers have now created unique nanoparticles that redirect immune cells away from the spinal cord, promoting regeneration [...]